Cargando...
Differential prescribing of antimuscarinic agents in older adults with cognitive impairment
BACKGROUND: Oral oxybutynin has been associated with the development of cognitive impairment. OBJECTIVE: The objective of this study was to describe the use of oral oxybutynin versus other antimuscarinics (e.g., tolterodine, darifenacin, solifenacin, trospium, fesoterodine, transdermal oxybutynin) i...
Gardado en:
| Publicado en: | Drugs Aging |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5904003/ https://ncbi.nlm.nih.gov/pubmed/29492862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40266-018-0531-9 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|